GHK-Cu is a naturally occurring copper-binding tripeptide studied for skin and connective tissue research applications. Patients can request a telehealth evaluation through the TelosRX Telehealth Portal.
What Is GHK-Cu?
GHK-Cu is a copper peptide composed of glycine, histidine, and lysine bound to copper. It is studied in preclinical research for skin and wound healing pathways.
GHK-Cu is not an FDA-approved drug. It is available through compounding pharmacies under valid prescription.
Common Discussion Points
Patients often raise GHK-Cu during evaluations for:
- Skin appearance and texture research
- Connective tissue support discussion
- Wound healing research interest
- Hair follicle research applications
A licensed provider determines clinical appropriateness individually.
Pre-PCAC July 2026 Regulatory Context
GHK-Cu is among the peptides under PCAC review ahead of the July 2026 meeting. Patients interested in compounded access should consult a licensed provider promptly.
How TelosRX Handles GHK-Cu
TelosRX is an online-first telehealth service. Patient evaluation is asynchronous, and compounded medications are prepared through our licensed pharmacy partner.
- Step 1: Complete an asynchronous telehealth intake at TelosRX.
- Step 2: Licensed provider review.
- Step 3: Prescription issued if clinically appropriate.
- Step 4: Compounded GHK-Cu ships discreetly to your door.
Important Compliance Information
GHK-Cu is not FDA-approved. Compounded preparations are prepared under federal compounding regulations.
Prescriptions require evaluation by a licensed healthcare provider. Approval is not guaranteed. Individual results vary.
TelosRX operates under LegitScript-certified telehealth standards.
Start your private evaluation at TelosRX.